EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid

Hiroshi Koga, Kwesi Teye, Arisa Sugawara, Masahiro Tsutsumi, Norito Ishii, Takekuni Nakama

Frontiers in Immunology · 15.06.2023 · 14

DOI: 10.3389/fimmu.2023.1135002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Immunology, online erschienen am 15.06.2023. Verfasst von Hiroshi Koga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Pemphigoid, Bullous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease (sAIBD). In addition to disease causing autoantibodies, several leukocyte subsets, including mast cells and eosinophils, play key roles in mediating skin inflammation. Detailed immunophenotyping and, more recently, the therapeutic effects of interleukin-4 (IL-4) receptor alpha inhibition in BP pointed to a prominent role of T helper 2 (Th2) cells. Among other cell types, IL-9 is expressed by Th2 and mast cells and potentially drives allergic, Th2-dominated inflammation. Although cytokines in BP have been relatively well investigated, the role of IL-9 has remained enigmatic. This study aimed to evaluate the effect of IL-9 in BP. Serum IL-9 levels were significantly elevated in patients with BP and decreased upon induction of remission. Serum IL-9 levels were not elevated in epidermolysis bullosa acquisita, another sAIBD. The time-course analysis using serum sets from four patients with BP revealed that serum IL-9 was a sensitive biomarker of BP. IL-9–positive cells infiltrated dominantly in BP lesions, especially in the blister fluid, and Th9 cells were abundant. Therefore, IL-9 was elevated in the serum and lesions of BP, which could be a biomarker of BP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, BullousHumansInterleukin-9VirulenceBlisterInflammationBiomarkers

Stichwörter der Autor:innen

autoantibodyautoimmune bullous diseasebasement membranecytokinepemphigoid

Substanzen

Interleukin-9Biomarkers

Autor:innen und Institutionen

  • Department of Dermatology, Kurume University School of Medicine, Fukuoka, Japan.
  • Kurume University Institute of Cutaneous Cell Biology, Kurume University, Fukuoka, Japan.

Zitieren

APA

Koga, H., Teye, K., Sugawara, A., Tsutsumi, M., Ishii, N., & Nakama, T. (2023). Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1135002

Vancouver

Koga H, Teye K, Sugawara A, Tsutsumi M, Ishii N, Nakama T. Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid. Frontiers in Immunology. 2023;14. doi:10.3389/fimmu.2023.1135002

BibTeX
@article{Koga2023,
  author = {Koga, Hiroshi and Teye, Kwesi and Sugawara, Arisa and Tsutsumi, Masahiro and Ishii, Norito and Nakama, Takekuni},
  title = {Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid},
  journal = {Frontiers in Immunology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fimmu.2023.1135002}
}
Kostenlos starten →